Amicus Therapeutics, Inc.
FOLD
$6.83
$0.131.94%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 14.74M | -6.73M | -15.70M | -48.42M | -33.84M |
| Total Depreciation and Amortization | 2.04M | 2.17M | 2.18M | 2.15M | 2.18M |
| Total Amortization of Deferred Charges | 597.00K | 574.00K | 560.00K | 531.00K | 536.00K |
| Total Other Non-Cash Items | 22.45M | 24.99M | 24.55M | 38.36M | 33.89M |
| Change in Net Operating Assets | -43.74M | -43.98M | 11.09M | -22.32M | 696.00K |
| Cash from Operations | -3.92M | -22.97M | 22.69M | -29.70M | 3.46M |
| Capital Expenditure | -288.00K | -356.00K | -1.10M | -1.81M | -1.73M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -20.10M | 34.63M | -20.88M | 9.35M | -22.23M |
| Cash from Investing | -20.39M | 34.27M | -21.98M | 7.54M | -23.96M |
| Total Debt Issued | -- | -- | -- | -- | 387.36M |
| Total Debt Repaid | -43.00K | 24.00K | -36.00K | -42.00K | -408.24M |
| Issuance of Common Stock | 1.97M | 20.96M | 863.00K | 3.45M | 32.24M |
| Repurchase of Common Stock | -828.00K | -2.79M | -1.68M | -16.72M | -1.57M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -1.59M |
| Cash from Financing | 1.10M | 18.19M | -857.00K | -13.31M | 8.21M |
| Foreign Exchange rate Adjustments | 3.11M | -5.03M | -294.00K | -1.82M | -3.91M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -20.10M | 24.46M | -437.00K | -37.28M | -16.20M |